How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Pharmacia Deutschland GmbH in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
10 clearance records and 0 recall records in the covered releases, across 1 source company names and 5 product codes. Dated history runs from May 2, 2002 to Jul 2, 2004.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| VARELISA PR3 ANCA, MODEL NUMBER 17748/17796K041043 · MOB | Pharmacia Deutschland GmbH | 510(k) | Jul 2, 2004FDA decision date |
| VARELISA HISTONE ANTIBODIES, MODEL 16496K040810 · LJM | Pharmacia Deutschland GmbH | 510(k) | May 14, 2004FDA decision date |
| VARELISA SSDNA ANTIBODIES, MODEL 14896K040811 · LRM | Pharmacia Deutschland GmbH | 510(k) | May 13, 2004FDA decision date |
| VARELISA B2 GLYCOPROTEIN I IGG ANTIBODIES, MODELS 18748 AND 18796K040449 · MSV | Pharmacia Deutschland GmbH | 510(k) | May 11, 2004FDA decision date |
| VARELISA B2 GLYCOPROTEIN I IGA ANTIBODIES, MODELS 18948 AND 18996K040450 · MSV | Pharmacia Deutschland GmbH | 510(k) | May 11, 2004FDA decision date |
| VARELISA B2 GLYCOPROTEIN I IGM ANTIBODIES, MODELS 18848 AND 18896K040451 · MSV | Pharmacia Deutschland GmbH | 510(k) | May 11, 2004FDA decision date |
| VARELISA B2 GLYCOPROTEIN I ANTIBODIES SCREEN, MODELS 19048 AND 19096K040452 · MSV | Pharmacia Deutschland GmbH | 510(k) | May 11, 2004FDA decision date |
| VARELISA CARDIOLIPIN IGG ANTIBODIES, MODELS 15548 & 15596K020752 · MID | Pharmacia Deutschland GmbH | 510(k) | May 2, 2002FDA decision date |
| VARELISA CARDIOLIPIN IGA ANTIBODIES, MODELS 15748 & 15796K020757 · MID | Pharmacia Deutschland GmbH | 510(k) | May 2, 2002FDA decision date |
| VARELISA CARDIOLIPIN IGM ANTIBODIES, MODELS 15648 & 15696K020758 · MID | Pharmacia Deutschland GmbH | 510(k) | May 2, 2002FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.